1HQY Stock Financial Analysis - HealthEquity, Inc. (BIT) Stock

HealthEquity, Inc.
IT ˙ BIT ˙ US42226A1079
€84.00 ↑5.00 (6.33%)
2025-09-04
SHARE PRICE
Overview
HealthEquity, Inc., based in the United States, operates predominantly within the health care sector, specifically focusing on technology-driven services that facilitate health savings accounts (HSAs) and other health financial services. Since its inception, the company has expanded its offerings to include reimbursement accounts such as FSAs, HRAs, as well as VEBA, and commuter benefits. A key project for HealthEquity involves integrating technology to simplify the management and accessibility of health accounts for both employers and account holders, emphasizing user-friendly platforms and 24/7 customer service. The company has also been actively working on partnerships and acquisitions to broaden its service capabilities and market reach, thereby consolidating its position as a leader in health account solutions in the U.S.
Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income
  • The revenue for HealthEquity, Inc. as of July 31, 2025 is 1,268.93 MM.
  • The operating income for HealthEquity, Inc. as of July 31, 2025 is 273.62 MM.
  • The net income for HealthEquity, Inc. as of July 31, 2025 is 145.84 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-07-31 1,268.93 273.62 145.84
2025-04-30 1,243.02 243.45 121.81
2025-01-31 1,199.77 202.87 96.70
2024-10-31 1,150.34 199.71 96.70
2024-07-31 1,099.13 179.19 105.67
2024-04-30 1,042.75 145.27 80.43
2024-01-31 999.59 128.13 55.71
2023-10-31 971.04 105.30 29.14
2023-07-31 937.91 83.80 12.82
2023-04-30 900.50 62.29 -8.41
2023-01-31 861.75 37.65 -26.14
2022-10-31 831.20 18.46 -58.75
2022-07-31 795.07 19.29 -62.15
2022-04-30 778.03 29.51 -55.31
2022-01-31 756.56 40.57 -44.29
2021-10-31 741.43 54.51 -6.10
2021-07-31 740.83 61.33 0.72
2021-04-30 727.76 65.22 4.39
2021-01-31 733.57 80.00 8.83
2020-10-31 746.60 106.84 3.28
2020-07-31
Income Statement: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-07-31
2025-04-30 1.40 1.37
2025-01-31 1.11 1.09
2024-10-31 1.12 1.09
2024-07-31 1.22 1.20
2024-04-30 0.94 0.92
2024-01-31 0.65 0.64
2023-10-31 0.34 0.34
2023-07-31 0.15 0.15
2023-04-30 -0.10 -0.10
2023-01-31 -0.31 -0.31
2022-10-31 -0.70 -0.70
2022-07-31 -0.74 -0.74
2022-04-30 -0.66 -0.66
2022-01-31 -0.53 -0.53
2021-10-31 -0.07 -0.08
2021-07-31 0.01 0.01
2021-04-30 0.06 0.06
2021-01-31 0.12 0.12
2020-10-31 0.05 0.05
2020-07-31 -0.28 -0.28
Cash Flow: Operations, Investing, Financing
  • The cash from operating activities for HealthEquity, Inc. as of July 31, 2025 is 366.90 MM.
  • The cash from investing activities for HealthEquity, Inc. as of July 31, 2025 is -53.74 MM.
  • The cash from financing activities for HealthEquity, Inc. as of July 31, 2025 is -335.59 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-07-31 366.90 -53.74 -335.59
2025-04-30 339.17 -251.65 -50.85
2025-01-31 339.86 -505.45 57.57
2024-10-31 341.18 -503.17 150.09
2024-07-31 307.74 -505.72 234.53
2024-04-30 276.72 -306.89 55.76
2024-01-31 242.83 -46.07 -47.04
2023-10-31 221.24 -45.08 -52.30
2023-07-31 212.07 -43.19 -55.42
2023-04-30 175.11 -54.06 -56.66
2023-01-31 150.65 -119.13 -2.67
2022-10-31 145.72 -580.15 -4.50
2022-07-31 120.06 -646.30 -50.62
2022-04-30 117.15 -645.65 -47.03
2022-01-31 141.00 -639.25 394.86
2021-10-31 151.34 -188.18 386.61
2021-07-31 181.12 -129.54 433.26
2021-04-30 197.51 -139.47 507.64
2021-01-31 181.62 -96.96 52.42
2020-10-31 151.66 -101.83 74.97
2020-07-31
Valuation Metrics : PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-07-31
2025-04-30
2025-01-31
2024-10-31
2024-07-31
2024-04-30
2024-01-31
2023-10-31
2023-07-31
2023-04-30
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-07-31
2025-04-30
2025-01-31
2024-10-31
2024-07-31
2024-04-30
2024-01-31
2023-10-31
2023-07-31
2023-04-30
2023-01-31
2022-10-31
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
2020-07-31
Management Effectiveness
  • The roa for HealthEquity, Inc. as of July 31, 2025 is 0.03.
  • The roe for HealthEquity, Inc. as of July 31, 2025 is 0.06.
  • The roic for HealthEquity, Inc. as of July 31, 2025 is 0.04.
  • The croic for HealthEquity, Inc. as of July 31, 2025 is 0.01.
  • The ocroic for HealthEquity, Inc. as of July 31, 2025 is 0.10.
Period End (TTM) ROA ROE ROIC CROIC OCROIC
2025-07-31 0.03 0.06 0.04 0.01 0.10
2025-04-30 0.04 0.06 0.04 0.01 0.10
2025-01-31 0.03 0.05 0.03 -0.03 0.11
2024-10-31 0.03 0.05 0.03 -0.00 0.10
2024-07-31 0.03 0.05 0.03 0.01 0.09
2024-04-30 0.03 0.04 0.03 0.01 0.09
2024-01-31 0.02 0.03 0.02 0.05 0.08
2023-10-31 0.01 0.02 0.01 0.04 0.08
2023-07-31 0.00 0.01 0.00 0.04 0.07
2023-04-30 -0.01 -0.01 -0.01 0.01 0.05
2023-01-31 -0.01 -0.01 -0.01 0.01 0.05
2022-10-31 -0.02 -0.03 -0.02 -0.15 0.05
2022-07-31 -0.02 -0.03 -0.02 -0.20 0.04
2022-04-30 -0.02 -0.03 -0.02 -0.04 0.05
2022-01-31 -0.02 -0.03 -0.02 -0.04 0.05
2021-10-31 0.00 0.00 0.00 0.17 0.06
2021-07-31 0.00 0.00 0.00 0.19 0.07
2021-04-30 0.00 0.00 0.00 0.19 0.07
2021-01-31 0.00 0.00 0.00 0.05 0.06
2020-10-31 -0.02 -0.02 -0.01 -0.22 0.05
2020-07-31 -0.02 -0.02 -0.01 -0.22 0.05
Gross Margins
  • The gross margin for HealthEquity, Inc. as of July 31, 2025 is 0.66.
  • The net margin for HealthEquity, Inc. as of July 31, 2025 is 0.10.
  • The operating margin for HealthEquity, Inc. as of July 31, 2025 is 0.20.
Gross Margin
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Net Margin
The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
Operating Margin
The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) Gross Margin Net Margin Operating Margin
2025-07-31 0.66 0.10 0.20
2025-04-30 0.66 0.10 0.20
2025-01-31 0.65 0.08 0.17
2024-10-31 0.65 0.08 0.17
2024-07-31 0.65 0.10 0.16
2024-04-30 0.63 0.08 0.14
2024-01-31 0.62 0.06 0.13
2023-10-31 0.61 0.03 0.11
2023-07-31 0.60 0.01 0.09
2023-04-30 0.57 -0.03 0.04
2023-01-31 0.57 -0.03 0.04
2022-10-31 0.55 -0.07 0.02
2022-07-31 0.55 -0.07 0.04
2022-04-30 0.56 -0.06 0.05
2022-01-31 0.56 -0.06 0.05
2021-10-31 0.57 0.00 0.08
2021-07-31 0.56 0.01 0.09
2021-04-30 0.56 0.01 0.09
2021-01-31 0.57 0.00 0.14
2020-10-31 0.58 -0.03 0.14
2020-07-31 0.58 -0.03 0.14
Identifiers and Descriptors
Central Index Key (CIK)1428336
Other Listings
MX:HQY
US:HQY $91.48
DE:2HE €81.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista